In order to thwart microbial growth and render the product contamination free, packaging plays a vital role and serves the purpose of safety throughout the shelf life of pharmaceuticals. In regulatory perspective, packaging has gained a significant importance and need critical compliance. The packaging equipment market for pharmaceutical has evolved from conventional packaging systems to modern and automated system, and it is well on its way to further growth. Our study suggests that packaging equipment market for pharmaceutical is expected to grow at a healthy CAGR from 2013 to 2020. This report analyses the global packaging equipment market for pharmaceutical, and investigates the reasons for its growth. The study investigates different market segments and identifies the most beneficial among them. The analysis creates the absolute picture of competition and recognizes the strategies of key leaders.
The extensive growth over the past years experienced by packaging equipment market for pharmaceutical is attributed to key factors, namely technological advancement in drug delivery technology and shift in demand from conventional to modern, flexible and automated system. Majority of the drugs are going off-patent in the near future and it can be a critical driver to heighten the growth of this market in near future. However, some of the factors responsible to suppress the growth of packaging equipment market, are high cost of raw material, raised competition and demand of renewed packaging equipment by smaller pharmaceutical manufacturers in APAC countries, to reduce the total cost of production. Asia ‐Pacific region is quite segregated and expected to show promising growth rate in near future, for pharmaceutical packaging equipment market. The reason for the growth of Asia-Pacific market is based on a fact that small manufactures potentially produce basic units and contribute to larger production capacity.
Packaging Equipment Market for Pharmaceutical by Package Type
Based on package type, packaging equipment market for pharmaceutical is sub-categorized as primary and secondary packaging equipments. Primary package offer direct contact with product, whereas secondary package offers contact with primary package. Primary packaging equipments are further subcategorized as blister packaging, sachet packaging, strip packaging, soft tube filling, aseptic filling and sealing, bottle filling and capping, counting, and others. Secondary packaging equipment is further classified into cartoning, wrapping, tray packing, case packaging, and others. Larger share of packaging equipment market lies in the area of primary packaging equipment due to shift in preference of end user to unit dosage forms.
Packaging Equipment Market for Pharmaceutical by Product Type
Based on type of products, packaging equipment market for pharmaceutical is classified into solid, semisolid, liquid and other products packaging equipments. In solid packaging equipment, tablet-packaging equipment holds the largest share. Due to high demand for safe and efficacious products, aseptic liquids packaging equipment is a emerging segment in liquid section.
Packaging Equipment Market for Pharmaceutical by Geography
Geographically, packaging equipment market for pharmaceutical is bifurcated into North America, Europe, Asia and LAMEA. North America and Asia-pacific dominates the packaging equipment market for pharmaceuticals. The reasons attributed are development of integrated pharmaceutical packaging lines that reduces downtime of packaging, high investment by big organizations, technological advancement and increase in number of FDA approved manufacturing sites in emerging economies. In Asia-Pacific region, India and China are promising locations.
The key leaders for packaging equipment market for pharmaceuticals include Robert Bosch GmbH, Uhlmann Group, Mg2 S.R.L, Multivac Group, Körber Ag and Marchesini Group S.p.a. Due to transition in global market of pharmaceutical packaging equipment and increased demand of blister packets along with aseptic pharmaceuticals, big players have launched various automatic and integrated packaging lines. Robert Bosch GmbH and Uhlmann Group are the key players involved in this strategy. The overall research in technological advancement of packaging equipment for pharmaceuticals is focused in novel and personalized drug delivery system.
High Level Analysis
The study is informative towards market drivers, restraints, and opportunities that lie in packaging equipment market for pharmaceuticals. The study offers deep insights to competitive landscape and focuses on the big players in the packaging equipment market for pharmaceuticals. The investigation done with Porter’s five-force model would assist in identifying the attractive markets. Innovative and advanced equipments are well differentiated from competitor’s product and this factor tends to increase the bargaining power of suppliers. High bargaining power of buyer is a result of shift in preferences to manufacture unit dosage forms to meet the patient needs. Stringent regulatory compliance is one of the major hurdles for new entrants. Low switching cost for buyers in emerging economies results in increasing the threat of substitute products. High demand for advanced machinery increases the operating barriers that keep the intensity of rivalry to downside. The report provides ample analysis of the key areas for growth and opportunities therein.
The packaging equipment market for pharmaceutical is segmented into three major categories such as package type, product type and geography.
MARKET BY PACKAGE TYPE
MARKET BY PRODUCT TYPE
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
This report studies CT-PET Scanners in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and ...
March 2017 | $3400 | View Details >>
Summary Mersana Therapeutics, Inc. (Mersana) formerly known as Nanopharma Corp, is a pharmaceutical company that develops immunoconjugate therapies to improve patients lives. The company offers pipeline product XMT-1522, for HER-2 targeted therapies based on its Dolaflexin platform. Mersana utilizes its Fleximer antibody drug conjugation (ADC) platform, Dolaflexin to design ADCs with ...
May 2016 | $250 | View Details >>
Gens report, Global Terguride Industry Report 2016 provides detailed market and segment level data on the Global and Chinese consumption of Terguride. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021. This report delivers an extensive overview of Global Terguride industry with a ...
December 2015 | $2800 | View Details >>
Schizophrenia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H2 2014’, provides an overview of the Schizophrenia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Schizophrenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
October 2014 | $2000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research